These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 22232734)
1. Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: a nested case-control study. Weinstein SJ; Stolzenberg-Solomon RZ; Kopp W; Rager H; Virtamo J; Albanes D Cancer Res; 2012 Mar; 72(5):1190-8. PubMed ID: 22232734 [TBL] [Abstract][Full Text] [Related]
2. Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer. Weinstein SJ; Mondul AM; Kopp W; Rager H; Virtamo J; Albanes D Int J Cancer; 2013 Jun; 132(12):2940-7. PubMed ID: 23180681 [TBL] [Abstract][Full Text] [Related]
3. Vitamin D-binding protein and pancreatic cancer: a nested case-control study. Piper MR; Freedman DM; Robien K; Kopp W; Rager H; Horst RL; Stolzenberg-Solomon RZ Am J Clin Nutr; 2015 Jun; 101(6):1206-15. PubMed ID: 25904602 [TBL] [Abstract][Full Text] [Related]
4. Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer. Anic GM; Weinstein SJ; Mondul AM; Männistö S; Albanes D PLoS One; 2014; 9(7):e102966. PubMed ID: 25036524 [TBL] [Abstract][Full Text] [Related]
5. Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma. Mondul AM; Weinstein SJ; Moy KA; Männistö S; Albanes D Int J Cancer; 2014 Jun; 134(11):2699-706. PubMed ID: 24214881 [TBL] [Abstract][Full Text] [Related]
6. Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer. Mondul AM; Weinstein SJ; Virtamo J; Albanes D Br J Cancer; 2012 Oct; 107(9):1589-94. PubMed ID: 22990651 [TBL] [Abstract][Full Text] [Related]
7. Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Weinstein SJ; Purdue MP; Smith-Warner SA; Mondul AM; Black A; Ahn J; Huang WY; Horst RL; Kopp W; Rager H; Ziegler RG; Albanes D Int J Cancer; 2015 Mar; 136(6):E654-64. PubMed ID: 25156182 [TBL] [Abstract][Full Text] [Related]
8. Serum vitamin D, vitamin D binding protein, and lung cancer survival. Anic GM; Weinstein SJ; Mondul AM; Männistö S; Albanes D Lung Cancer; 2014 Dec; 86(3):297-303. PubMed ID: 25456734 [TBL] [Abstract][Full Text] [Related]
9. Association of thyroid cancer risk with plasma 25-hydroxyvitamin D and vitamin D binding protein: a case-control study in China. Hu MJ; Niu QS; Wu HB; Lu XL; Wang L; Tong XR; Huang F J Endocrinol Invest; 2020 Jun; 43(6):799-808. PubMed ID: 31863361 [TBL] [Abstract][Full Text] [Related]
10. Serum 25-hydroxyvitamin D, vitamin D binding protein, and prostate cancer risk in black men. Layne TM; Weinstein SJ; Graubard BI; Ma X; Mayne ST; Albanes D Cancer; 2017 Jul; 123(14):2698-2704. PubMed ID: 28369777 [TBL] [Abstract][Full Text] [Related]
11. Vitamin D and Vitamin D-binding protein and risk of bladder cancer: A nested case-control study in the Norwegian Janus Serum Bank Cohort. Hektoen HH; Robsahm TE; Stenehjem JS; Axcrona K; Babigumira R; Mondul AM; Gislefoss RE; Andreassen BK Cancer Med; 2021 Jun; 10(12):4107-4116. PubMed ID: 34080787 [TBL] [Abstract][Full Text] [Related]
12. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. Stolzenberg-Solomon RZ; Vieth R; Azad A; Pietinen P; Taylor PR; Virtamo J; Albanes D Cancer Res; 2006 Oct; 66(20):10213-9. PubMed ID: 17047087 [TBL] [Abstract][Full Text] [Related]
13. Plasma free 25-hydroxyvitamin D, vitamin D binding protein, and risk of breast cancer in the Nurses' Health Study II. Wang J; Eliassen AH; Spiegelman D; Willett WC; Hankinson SE Cancer Causes Control; 2014 Jul; 25(7):819-27. PubMed ID: 24748579 [TBL] [Abstract][Full Text] [Related]
14. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance. Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987 [TBL] [Abstract][Full Text] [Related]
15. Plasma 25-hydroxyvitamin D and risk of pancreatic cancer. Wolpin BM; Ng K; Bao Y; Kraft P; Stampfer MJ; Michaud DS; Ma J; Buring JE; Sesso HD; Lee IM; Rifai N; Cochrane BB; Wactawski-Wende J; Chlebowski RT; Willett WC; Manson JE; Giovannucci EL; Fuchs CS Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):82-91. PubMed ID: 22086883 [TBL] [Abstract][Full Text] [Related]
16. Free vitamin D Grut V; Biström M; Salzer J; Stridh P; Lindam A; Alonso-Magdalena L; Andersen O; Jons D; Gunnarsson M; Vrethem M; Hultdin J; Sundström P Eur J Neurol; 2022 Aug; 29(8):2335-2342. PubMed ID: 35582958 [TBL] [Abstract][Full Text] [Related]
17. Serum 25-hydroxyvitamin D and risk of lung cancer in male smokers: a nested case-control study. Weinstein SJ; Yu K; Horst RL; Parisi D; Virtamo J; Albanes D PLoS One; 2011; 6(6):e20796. PubMed ID: 21695165 [TBL] [Abstract][Full Text] [Related]
18. In healthy adults, biological activity of vitamin D, as assessed by serum PTH, is largely independent of DBP concentrations. Dastani Z; Berger C; Langsetmo L; Fu L; Wong BY; Malik S; Goltzman D; Cole DE; Richards JB J Bone Miner Res; 2014 Feb; 29(2):494-9. PubMed ID: 23857798 [TBL] [Abstract][Full Text] [Related]
19. Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study. Albanes D; Mondul AM; Yu K; Parisi D; Horst RL; Virtamo J; Weinstein SJ Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1850-60. PubMed ID: 21784952 [TBL] [Abstract][Full Text] [Related]
20. Association of 25-hydroxyvitamin D with areal and volumetric measures of bone mineral density and parathyroid hormone: impact of vitamin D-binding protein and its assays. Jemielita TO; Leonard MB; Baker J; Sayed S; Zemel BS; Shults J; Herskovitz R; Denburg MR Osteoporos Int; 2016 Feb; 27(2):617-26. PubMed ID: 26359185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]